Skip to main content
Smart Investors Daily
Definitive Healthcare Corp. logo

NASDAQ · DH

Definitive Healthcare Corp.

Healthcare · Medical - Healthcare Information Services

$0.93

Down-$0.00 (-0.30%)

Updated Oct 4, 2026, 1:46 AM

SID Score

4.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
236.33M
P/E ratio
-1.26
Dividend yield
0.00%
52-week range
$0.61 – $1.29
Volume
207.16K
Avg. volume
309.01K

Price performance · DH

DH price history

1M range · 0 trading sessions · Daily adjusted prices

DH does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest DH news

The latest Smart Investors Daily articles mentioning DH.

DH research

Overview

Company profile and research snapshot.

Company profile

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Hold
Average target
$3.38
Implied upside
—
Analysts
21
DH recent ratings
DateFirmRatingTarget
Aug 11, 2026Morgan StanleyEqual-Weight—
Jun 29, 2026B of A SecuritiesUnderperform—
Mar 30, 2026BarclaysUnderweight—
Feb 27, 2026Stephens & Co.Equal-Weight—
Feb 27, 2026Canaccord GenuityHold—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 2, 2026

Special Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Advent International

FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- The special committee (the “Special Committee”) of the Board of Directors of Definitive Healthcare Corp. (the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that it has received a non-binding indication of interest (the “Proposal”), dated as of September 1, 2026, from Advent International, L.P., on behalf of certain of its managed funds (collectively, “Advent”), to acquire all of the outst

Yahoo · Sep 2, 2026

Definitive Healthcare Appoints Clay Ritchey as CEO

Mr. Ritchey brings more than 25 years of deep healthcare expertise to DefinitiveFRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Board of Directors has appointed Clay Ritchey as the Company’s next Chief Executive Officer and as a member of the Board of Directors, each effective September 8, 2026. Mr. Ritchey succeeds Kevin Coop, who departe

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.